0001209191-11-039009.txt : 20110708
0001209191-11-039009.hdr.sgml : 20110708
20110708210306
ACCESSION NUMBER: 0001209191-11-039009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110706
FILED AS OF DATE: 20110708
DATE AS OF CHANGE: 20110708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE
CENTRAL INDEX KEY: 0001103390
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943200380
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-652-6500
MAIL ADDRESS:
STREET 1: 4939 DIRECTORS PLACE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE
DATE OF NAME CHANGE: 20000127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS STEPHEN
CENTRAL INDEX KEY: 0001131146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33734
FILM NUMBER: 11960450
MAIL ADDRESS:
STREET 1: NEUROGEN CORP
STREET 2: 35 NORTHEAST INDUSTRIAL RD
CITY: BRANFORD
STATE: CT
ZIP: 06405
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-07-06
0
0001103390
Ardea Biosciences, Inc./DE
RDEA
0001131146
DAVIS STEPHEN
4939 DIRECTORS PLACE
SAN DIEGO
CA
92121
0
1
0
0
EVP & COO
Common Stock
2011-07-06
4
F
0
191
25.33
D
19351
D
Common Stock
2011-07-06
4
S
0
700
25.6529
D
18651
D
Represents vested shares of restricted stock that were withheld by the Issuer to satisfy the tax liability associated with the 521 shares that vested on July 6, 2011.
The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010.
The range of sales prices received was $25.39 to $25.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
/s/ Stephen Davis
2011-07-08